Testing for Direct Oral Anticoagulants (DOACs): When and How - Webinar

While testing for direct oral anticoagulants (DOACs) is not warranted, incident serious adverse events may benefit from quantitative measurement of the DOAC level. Moreover, in frail patients, DOAC prescription and use may be individually tailored by limited laboratory monitoring. The presentation will discuss types of assays and potential indications for laboratory monitoring, based on our clinical experience with different DOACs.

Anticoagulation DOACs TAVR (Transcatheter Aortic Valve Replacement) CVD (cardiovascular disease) Bleeding MCI (Myocardial Infarction) Hemostasis cardiovascular diseases coronary artery disease antiplatelet therapy testing and monitoring direct oral anticoagulants direct oral anticoagulants